Vaccines
21 October 2013
Immunology Data Further Underline the Positive Outcome of a Phase IIb Trial of Anergis’ Birch Pollen Allergy Vaccine AllerT21 October 2013
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial15 October 2013
immatics Closes €34 Million Financing to Complete Phase 3 Development of IMA901 for Renal Cancer10 October 2013
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-human Primates9 October 2013
Japanese encephalitis vaccine achieves WHO prequalification, a key step in expanding access and protecting more children8 October 2013
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate4 October 2013
Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine Candidate1 October 2013
Circassia’s Rapid Grass Allergy Treatment Achieves Significant Symptom Reduction During Hay Fever Season30 September 2013
MOLOGEN AG: Final analysis confirmed preliminary results of renal cancer vaccine MGN160126 September 2013
Takeda Submits New Drug Application in Japan for TAK-816, a Haemophilus Influenzae type b (Hib) vaccine26 September 2013
NovaDigm Therapeutics Initiates Phase 1b/2a Clinical Trial with NDV-3 Vaccine in Recurrent Vulvovaginal Candidiasis (RVVC)25 September 2013
Merck Serono Announces Decision to Continue the Development of Tecemotide in Stage III Non-Small Cell Lung Cancer20 September 2013
Fluenz Tetra, four-strain nasal spray vaccine, receives positive opinion in EU from CHMP for the prevention of seasonal influenza in childrenNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports